Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19
ObjectiveThe relationships between circulating inflammatory proteins and COVID-19 have been observed in previous cohorts. However, it is not unclear which circulating inflammatory proteins may boost the risk of or protect against COVID-19.MethodsWe performed Mendelian randomization (MR) analysis usi...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2024-02-01
|
| Серія: | Frontiers in Immunology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1352583/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|